doi:10.48130/vns-0026-0040

[1]

Thyparampil P, Yen MT. 2016. Compressive optic neuropathy in thyroid eye disease. International Ophthalmology Clinics 56:51−67

doi: 10.1097/IIO.0000000000000096

[2]

Currò N, Guastella C, Pirola G, Calonghi B, Bottari de Castello A, et al. 2023. Clinical and visual outcomes of dysthyroid optic neuropathy after surgical orbital decompression. Thyroid 33:743−751

doi: 10.1089/thy.2022.0564

[3]

Tu Y, Jin H, Xu M, Liu W, Hu X, et al. 2023. Reduced contrast sensitivity function correlated with superficial retinal capillary plexus impairment in early stage of dysthyroid optic neuropathy. Eye and Vision 10:11

doi: 10.1186/s40662-023-00328-3

[4]

Blandford AD, Zhang D, Chundury RV, Perry JD. 2017. Dysthyroid optic neuropathy: update on pathogenesis, diagnosis, and management. Expert Review of Ophthalmology 12:111−121

doi: 10.1080/17469899.2017.1276444

[5]

Pelewicz-Sowa M, Miśkiewicz P. 2023. Dysthyroid optic neuropathy: emerging treatment strategies. Journal of Endocrinological Investigation 46:1305−1316

doi: 10.1007/s40618-023-02036-0

[6]

Tagami M, Honda S, Azumi A. 2022. Insights into current management strategies for dysthyroid optic neuropathy: a review. Clinical Ophthalmology 16:841−850

doi: 10.2147/OPTH.S284609

[7]

Goel R, Shah S, Sundar G, Arora R, Gupta S, et al. 2023. Orbital and ocular perfusion in thyroid eye disease. Survey of Ophthalmology 68:481−506

doi: 10.1016/j.survophthal.2023.01.003

[8]

Wang M, Jiang X, Geng J, Hui S, Li D. 2023. Outcomes of patients with dysthyroid optic neuropathy treated with intravenous corticosteroids and/or orbital decompression surgery: a systematic review and meta-analysis. The Journal of Clinical Endocrinology & Metabolism 108:2717−2727

doi: 10.1210/clinem/dgad211

[9]

Callet M, Farah E, Stolowy N, Robelin L, Bouché C, et al. 2026. Contrast sensitivity and quality of life after orbital decompression for dysthyroid optic neuropathy. Graefe’s Archive for Clinical and Experimental Ophthalmology 264:2171–2178

doi: 10.1007/s00417-026-07133-3

[10]

Zou M, Wu D, Cheng Y, Qin H, Yang Z, et al. 2026. The diagnostic value of mean apparent propagator-MRI in dysthyroid optic neuropathy: a quantitative analysis of the entire visual pathway. CNS Neuroscience & Therapeutics 32:e70793

doi: 10.1002/cns.70793

[11]

Hu R, Tang S, Liu X, Liu Z, Cui Z, et al. 2025. Predicting dysthyroid optic neuropathy in moderate-to-severe thyroid eye disease: a clinically applicable nomogram. European Thyroid Journal 14:e250226

doi: 10.1530/ETJ-25-0226

[12]

Zhang Y, Mao Y, Zheng J, Wang L, Wu M, et al. 2026. OptiDON-guard: an ensemble model for identification of dysthyroid optic neuropathy using optical coherence tomography angiography. Translational Vision Science & Technology 15:4

doi: 10.1167/tvst.15.4.4

[13]

Dolman PJ. 2021. Dysthyroid optic neuropathy: evaluation and management. Journal of Endocrinological Investigation 44:421−429

doi: 10.1007/s40618-020-01361-y

[14]

Dayan CM, Dayan MR. 2007. Dysthyroid optic neuropathy: a clinical diagnosis or a definable entity? The British Journal of Ophthalmology 91:409−410

doi: 10.1136/bjo.2006.110932

[15]

Rutkowska-Hinc B, Maj E, Jabłońska A, Milczarek-Banach J, Bednarczuk T, et al. 2018. Prevalence of radiological signs of dysthyroid optic neuropathy in magnetic resonance imaging in patients with active, moderate-to-severe, and very severe Graves orbitopathy. European Thyroid Journal 7:88−94

doi: 10.1159/000486828

[16]

Agarwal A, Kedar S. 2015. Prognosis and treatment of visual field defects. Seminars in Neurology 35:549−556

doi: 10.1055/s-0035-1563573

[17]

Almog Y, Nemet A. 2010. The correlation between visual acuity and color vision as an indicator of the cause of visual loss. American Journal of Ophthalmology 149:1000−1004

doi: 10.1016/j.ajo.2010.01.011

[18]

Tan K, Liu Y, Zhang Y, Chen X, Li J, et al. 2026. Retinal structure and microcirculation alterations in dysthyroid optic neuropathy: a comprehensive OCTA study. Asia-Pacific Journal of Ophthalmology 15:100303

doi: 10.1016/j.apjo.2026.100303

[19]

Garip-Kuebler A, Halfter K, Reznicek L, Klingenstein A, Priglinger S, et al. 2021. Subclinical dysthyroid optic neuropathy: tritan deficiency as an early sign of dysthyroid optic neuropathy. The British Journal of Ophthalmology 105:1019−1023

doi: 10.1136/bjophthalmol-2020-316433

[20]

Bartalena L, Kahaly GJ, Baldeschi L, Dayan CM, Eckstein A, et al. 2021. The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy. European Journal of Endocrinology 185:G43−G67

doi: 10.1530/EJE-21-0479

[21]

Zhang H, Lu T, Liu Y, Jiang M, Wang Y, et al. 2024. Application of quantitative MRI in thyroid eye disease: imaging techniques and clinical practices. Journal of Magnetic Resonance Imaging 60:827−847

doi: 10.1002/jmri.29114

[22]

Zhou J, Yuan Q, Pu XY, Lu JL, Liu H, et al. 2025. Multiparametric MRI for diagnosing dysthyroid optic neuropathy: added value of magnetization transfer imaging. Korean Journal of Radiology 26:704−715

doi: 10.3348/kjr.2024.1188

[23]

Li Y, Zhu Z, Lu Y, Lin Q, Liu M, et al. 2025. Correlation between orbital imaging features of thyroid-associated ophthalmopathy and pupillary light reflex measurement. Frontiers in Medicine 12:1552729

doi: 10.3389/fmed.2025.1552729

[24]

Moledina M, Lee V, Bhatia K, Madani G, Feeney C, et al. 2025. Radiological activity score (RAS)—MRI characteristics in dysthyroid optic neuropathy in a multi-ethnic thyroid eye disease population. Clinical Endocrinology 103:385−395

doi: 10.1111/cen.15272

[25]

Wu HY, Luo B, Yuan G, Wang QX, Liu P, et al. 2024. A prediction model for detecting dysthyroid optic neuropathy based on clinical factors and imaging markers of the optic nerve and cerebrospinal fluid in the optic nerve sheath. Current Medical Science 44:827−832

doi: 10.1007/s11596-024-2890-2

[26]

Song C, Luo Y, Huang W, Duan Y, Deng X, et al. 2023. Extraocular muscle volume index at the orbital apex with optic neuritis: a combined parameter for diagnosis of dysthyroid optic neuropathy. European Radiology 33:9203−9212

doi: 10.1007/s00330-023-09848-x

[27]

Zhang T, Chen R, Ye H, Xiao W, Yang H. 2022. Orbital MRI 3D reconstruction based on volume rendering in evaluating dysthyroid optic neuropathy. Current Eye Research 47:1179−1185

doi: 10.1080/02713683.2022.2066697

[28]

Zou M, Wu D, Zhu H, Huang X, Zhao X, et al. 2022. Multiparametric quantitative MRI for the evaluation of dysthyroid optic neuropathy. European Radiology 32:1931−1938

doi: 10.1007/s00330-021-08300-2

[29]

Wu H, Luo B, Zhao Y, Yuan G, Wang Q, et al. 2022. Radiomics analysis of the optic nerve for detecting dysthyroid optic neuropathy, based on water-fat imaging. Insights into Imaging 13:154

doi: 10.1186/s13244-022-01292-7

[30]

Liu P, Luo B, Zhai LH, Wu HY, Wang QX, et al. 2022. Multi-parametric diffusion tensor imaging of the optic nerve for detection of dysthyroid optic neuropathy in patients with thyroid-associated ophthalmopathy. Frontiers in Endocrinology 13:851143

doi: 10.3389/fendo.2022.851143

[31]

Wu H, Luo B, Yuan G, Wang Q, Liu P, et al. 2021. The diagnostic value of the IDEAL-T2WI sequence in dysthyroid optic neuropathy: a quantitative analysis of the optic nerve and cerebrospinal fluid in the optic nerve sheath. European Radiology 31:7419−7428

doi: 10.1007/s00330-021-08030-5

[32]

Jiang M, Zhang H, Liu Y, Song X, Song Y, et al. 2025. White matter alterations of visual pathway in thyroid eye disease: a fixel-based analysis. Journal of Magnetic Resonance Imaging 61:337−346

doi: 10.1002/jmri.29387

[33]

Tu Y, Huang P, Mao C, Liu X, Gao J. 2022. Abnormal functional connectivity density in patients with dysthyroid optic neuropathy. Ophthalmic Research 65:171−179

doi: 10.1159/000512755

[34]

Lu J, Hu H, Zhou J, Jiang W, Pu X, et al. 2024. Altered static and dynamic spontaneous brain activity in patients with dysthyroid optic neuropathy: a resting-state fMRI study. Frontiers in Neuroscience 18:1530967

doi: 10.3389/fnins.2024.1530967

[35]

Zhou J, Liu J, Lu JL, Pu XY, Chen HH, et al. 2025. White-matter alterations in dysthyroid optic neuropathy: a diffusion kurtosis imaging study using tract-based spatial statistics. Japanese Journal of Radiology 43:603−611

doi: 10.1007/s11604-024-01710-4

[36]

Zhou J, Chen W, Jiang WH, Wu Q, Lu JL, et al. 2024. Altered static and dynamic brain functional topological organization in patients with dysthyroid optic neuropathy. The Journal of Clinical Endocrinology and Metabolism 109:2071−2082

doi: 10.1210/clinem/dgae062

[37]

Liu P, Luo B, Feng Y, Chen L, Zhao YL, et al. 2023. Aberrant spontaneous brain activity in patients with thyroid-associated ophthalmopathy with and without optic neuropathy: a resting-state functional MRI study. European Radiology 33:7981−7991

doi: 10.1007/s00330-023-09829-0

[38]

Jiang YP, Yang YC, Tang LY, Ge QM, Shi WQ, et al. 2021. Altered spontaneous brain activity patterns in dysthyroid optic neuropathy: a resting-state fMRI study. Journal of Integrative Neuroscience 20:375−383

doi: 10.31083/j.jin2002037

[39]

Zhang H, Liu Y, Jiang M, Xia D, Peng Y, et al. 2024. Optic nerve compression associated with visual cortex functional alteration in dysthyroid optic neuropathy: a combined orbital and brain imaging study. CNS Neuroscience & Therapeutics 30:e14820

doi: 10.1111/cns.14820

[40]

Hu H, Zhou J, Jiang WH, Wu Q, Pu XY, et al. 2024. Diagnosis of dysthyroid optic neuropathy: combined value of orbital MRI and intracranial visual pathway diffusion kurtosis imaging. European Radiology 34:5401−5411

doi: 10.1007/s00330-024-10615-9

[41]

Jiang S, Li H, Zhang L, Mu W, Zhang Y, et al. 2025. Generic Diagramming Platform (GDP): a comprehensive database of high-quality biomedical graphics. Nucleic Acids Research 53:D1670−D1676

doi: 10.1093/nar/gkae973

[42]

Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, et al. 2021. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ 372:n160

doi: 10.1136/bmj.n160

[43]

Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, et al. 2011. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Annals of Internal Medicine 155:529−536

doi: 10.7326/0003-4819-155-8-201110180-00009

[44]

Wiersinga WM, Bartalena L. 2002. Epidemiology and prevention of Graves' ophthalmopathy. Thyroid 12:855−860

doi: 10.1089/105072502761016476

[45]

Barrett L, Glatt HJ, Burde RM, Gado MH. 1988. Optic nerve dysfunction in thyroid eye disease: CT. Radiology 167:503−507

doi: 10.1148/radiology.167.2.3357962

[46]

Zang Y, Jiang T, Lu Y, He Y, Tian L. 2004. Regional homogeneity approach to fMRI data analysis. NeuroImage 22:394−400

doi: 10.1016/j.neuroimage.2003.12.030

[47]

Zang YF, He Y, Zhu CZ, Cao QJ, Sui MQ, et al. 2007. Altered baseline brain activity in children with ADHD revealed by resting-state functional MRI. Brain & Development 29:83−91

doi: 10.1016/j.braindev.2006.07.002

[48]

van den Heuvel MP, Sporns O. 2019. A cross-disorder connectome landscape of brain dysconnectivity. Nature Reviews Neuroscience 20:435−446

doi: 10.1038/s41583-019-0177-6

[49]

Zalesky A, Fornito A, Bullmore ET. 2010. Network-based statistic: identifying differences in brain networks. NeuroImage 53:1197−1207

doi: 10.1016/j.neuroimage.2010.06.041

[50]

Heather Hsu CC, Rolls ET, Huang CC, Chong ST, Zac Lo CY, et al. 2020. Connections of the human orbitofrontal cortex and inferior frontal gyrus. Cereb Cerebral 30:5830−5843

doi: 10.1093/cercor/bhaa160

[51]

Bannerman DM, Rawlins JNP, McHugh SB, Deacon RMJ, Yee BK, et al. 2004. Regional dissociations within the hippocampus—memory and anxiety. Neuroscience & Biobehavioral Reviews 28:273−283

doi: 10.1016/j.neubiorev.2004.03.004

[52]

Friederici AD, Kotz SA, Scott SK, Obleser J. 2010. Disentangling syntax and intelligibility in auditory language comprehension. Human Brain Mapping 31:448−457

doi: 10.1002/hbm.20878

[53]

Zhang H, Liu Y, Zhang Z, Jiang M, Tao X, et al. 2024. Neuroimaging in thyroid eye disease: a systematic review. Autoimmunity Reviews 23:103667

doi: 10.1016/j.autrev.2024.103667

[54]

Zah-Bi G, Abeillon-du Payrat J, Vie AL, Bournaud-Salinas C, Jouanneau E, et al. 2019. Minimal-access endoscopic endonasal management of dysthyroid optic neuropathy: the dysthone study. Neurosurgery 85:E1059−E1067

doi: 10.1093/neuros/nyz268

[55]

Gonçalves ACP, Silva LN, Gebrim EMMS, Matayoshi S, Monteiro MLR. 2012. Predicting dysthyroid optic neuropathy using computed tomography volumetric analyses of orbital structures. Clinics 67:891−896

doi: 10.6061/clinics/2012(08)06

[56]

Gonçalves ACP, Silva LN, Gebrim EMMS, Monteiro MLR. 2012. Quantification of orbital apex crowding for screening of dysthyroid optic neuropathy using multidetector CT. AJNR American Journal of Neuroradiology 33:1602−1607

doi: 10.3174/ajnr.A3029

[57]

McKeag D, Lane C, Lazarus JH, Baldeschi L, Boboridis K, et al. 2007. Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) survey. The British Journal of Ophthalmology 91:455−458

doi: 10.1136/bjo.2006.094607

[58]

Saitakis G, Chwalisz BK. 2022. Optic perineuritis. Current Opinion in Ophthalmology 33:519−524

doi: 10.1097/ICU.0000000000000900

[59]

Gerdes CM, Kijowski R, Reeder SB. 2007. IDEAL imaging of the musculoskeletal system: robust water fat separation for uniform fat suppression, marrow evaluation, and cartilage imaging. AJR American Journal of Roentgenology 189:W284−W291

doi: 10.2214/AJR.07.2593

[60]

Humbert IA, Reeder SB, Porcaro EJ, Kays SA, Brittain JH, et al. 2008. Simultaneous estimation of tongue volume and fat fraction using IDEAL-FSE. Journal of Magnetic Resonance Imaging 28:504−508

doi: 10.1002/jmri.21431

[61]

Kaichi Y, Tanitame K, Itakura H, Ohno H, Yoneda M, et al. 2016. Orbital fat volumetry and water fraction measurements using T2-weighted FSE-IDEAL imaging in patients with thyroid-associated orbitopathy. AJNR American Journal of Neuroradiology 37:2123−2128

doi: 10.3174/ajnr.A4859

[62]

Hufnagel TJ, Hickey WF, Cobbs WH, Jakobiec FA, Iwamoto T, et al. 1984. Immunohistochemical and ultrastructural studies on the exenterated orbital tissues of a patient with Graves' disease. Ophthalmology 91:1411−1419

doi: 10.1016/s0161-6420(84)34152-5

[63]

Song SK, Sun SW, Ju WK, Lin SJ, Cross AH, et al. 2003. Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia. NeuroImage 20:1714−1722

doi: 10.1016/j.neuroimage.2003.07.005

[64]

Sullivan EV, Rohlfing T, Pfefferbaum A. 2010. Quantitative fiber tracking of lateral and interhemispheric white matter systems in normal aging: relations to timed performance. Neurobiology of Aging 31:464−481

doi: 10.1016/j.neurobiolaging.2008.04.007

[65]

Wang D, Wang C, Duan X, Yang Z, Bai Z, et al. 2018. MR T2 value of the tibial nerve can be used as a potential non-invasive and quantitative biomarker for the diagnosis of diabetic peripheral neuropathy. Eur Radiol 28:1234−1241

doi: 10.1007/s00330-017-5043-1

[66]

Eguchi Y, Enomoto K, Sato T, Watanabe A, Sakai T, et al. 2020. Simultaneous MR neurography and apparent T2 mapping of cervical nerve roots before microendoscopic surgery to treat patient with radiculopathy due to cervical disc herniation: preliminary results. Journal of Clinical Neuroscience 74:213−219

doi: 10.1016/j.jocn.2019.08.099

[67]

Henkelman RM, Stanisz GJ, Graham SJ. 2001. Magnetization transfer in MRI: a review. NMR in Biomedicine 14:57−64

doi: 10.1002/nbm.683

[68]

Kollmer J, Kästel T, Jende JME, Bendszus M, Heiland S. 2018. Magnetization transfer ratio in peripheral nerve tissue: does it depend on age or location? Investigative Radiology 53:397−402

doi: 10.1097/RLI.0000000000000455

[69]

Yu F, Duong T, Tantiwongkosi B. 2015. Advanced MR imaging of the visual pathway. Neuroimaging Clinics of North America 25:383−393

doi: 10.1016/j.nic.2015.05.003

[70]

Hickman SJ, Miszkiel KA, Plant GT, Miller DH. 2005. The optic nerve sheath on MRI in acute optic neuritis. Neuroradiology 47:51−55

doi: 10.1007/s00234-004-1308-x

[71]

Deng W, Liu C, Parra C, Sims JR, Faiq MA, et al. 2020. Quantitative imaging of the clearance systems in the eye and the brain. Quantitative Imaging in Medicine and Surgery 10:1−14

doi: 10.21037/qims.2019.11.18

[72]

Wang X, Lou N, Eberhardt A, Yang Y, Kusk P, et al. 2020. An ocular glymphatic clearance system removes β-amyloid from the rodent eye. Science Translational Medicine 12:eaaw3210

doi: 10.1126/scitranslmed.aaw3210

[73]

Mathieu E, Gupta N, Ahari A, Zhou X, Hanna J, et al. 2017. Evidence for cerebrospinal fluid entry into the optic nerve via a glymphatic pathway. Investigative Ophthalmology & Visual Science 58:4784−4791

doi: 10.1167/iovs.17-22290

[74]

Jacobsen HH, Ringstad G, Jørstad Ø K, Moe MC, Sandell T, et al. 2019. The human visual pathway communicates directly with the subarachnoid space. Investigative Ophthalmology & Visual Science 60:2773−2780

doi: 10.1167/iovs.19-26997

[75]

Mathieu E, Gupta N, Paczka-Giorgi LA, Zhou X, Ahari A, et al. 2018. Reduced cerebrospinal fluid inflow to the optic nerve in glaucoma. Investigative Opthalmology & Visual Science 59:5876−5884

doi: 10.1167/iovs.18-24521

[76]

Zhang H, Jiang M, Liu Y, Lee XN, Fang Z, et al. 2025. Glymphatic system dysfunction in thyroid eye disease associated with disease activity and duration. Journal of Inflammation Research 18:10489−10498

doi: 10.2147/JIR.S532401

[77]

Dhande OS, Huberman AD. 2014. Retinal ganglion cell maps in the brain: implications for visual processing. Current Opinion in Neurobiology 24:133−142

doi: 10.1016/j.conb.2013.08.006

[78]

Dinkin M. 2017. Trans-synaptic retrograde degeneration in the human visual system: slow, silent, and real. Current Neurology and Neuroscience Reports 17:16

doi: 10.1007/s11910-017-0725-2

[79]

Jensen JH, Helpern JA. 2010. MRI quantification of non-Gaussian water diffusion by kurtosis analysis. NMR in Biomedicine 23:698−710

doi: 10.1002/nbm.1518

[80]

Steven AJ, Zhuo J, Melhem ER. 2014. Diffusion kurtosis imaging: an emerging technique for evaluating the microstructural environment of the brain. AJR American Journal of Roentgenology 202:W26−W33

doi: 10.2214/AJR.13.11365

[81]

Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, et al. 2006. Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. NeuroImage 31:1487−1505

doi: 10.1016/j.neuroimage.2006.02.024

[82]

Kuchling J, Backner Y, Oertel FC, Raz N, Bellmann-Strobl J, et al. 2018. Comparison of probabilistic tractography and tract-based spatial statistics for assessing optic radiation damage in patients with autoimmune inflammatory disorders of the central nervous system. NeuroImage: Clinical 19:538−550

doi: 10.1016/j.nicl.2018.05.004

[83]

Huang X, Tong Y, Qi CX, Xu YT, Dan HD, et al. 2019. Disrupted topological organization of human brain connectome in diabetic retinopathy patients. Neuropsychiatric Disease and Treatment 15:2487−2502

doi: 10.2147/NDT.S214325

[84]

Barkhof F, Haller S, Rombouts SARB. 2014. Resting-state functional MR imaging: a new window to the brain. Radiology 272:29−49

doi: 10.1148/radiol.14132388

[85]

Peng J, Yang J, Li J, Lei D, Li N, et al. 2022. Disrupted brain functional network topology in essential tremor patients with poor sleep quality. Frontiers in Neuroscience 16:814745

doi: 10.3389/fnins.2022.814745

[86]

Lei C, Lyu X, Ren Y, Wei D, Zhang S, et al. 2025. Clinical features of Chinese patients with thyroid eye disease: a multicenter retrospective study. Thyroid 35:1187−1197

doi: 10.1177/10507256251359559

[87]

Lim NC, Sundar G, Amrith S, Lee KO. 2015. Thyroid eye disease: a Southeast Asian experience. The British Journal of Ophthalmology 99:512−518

doi: 10.1136/bjophthalmol-2014-305649

[88]

Xu J, Gao C, Zhang J, Lu J, Xuan Y, et al. 2025. Advancements in imaging technologies and AI integration for neurodegenerative disease management: a narrative review. Molecular Imaging 24:15353508251393056

doi: 10.1177/15353508251393056

[89]

Ma Q, Hai Y, Duan Y, Yu G, Song C, et al. 2025. Inflammatory profiling and immune cell infiltration in dysthyroid optic neuropathy: insights from bulk RNA sequencing. Frontiers in Immunology 16:1550694

doi: 10.3389/fimmu.2025.1550694

[90]

Tu Y, Yan C, Chen L, Liu W, Hu X, et al. 2026. Retinal capillary density reduction contributes to dysthyroid optic neuropathy via an L-arginine-NO pathway: a metabonomics and clinical trial study. MedComm 7:e70652

doi: 10.1002/mco2.70652

[91]

Archibald SJ, Holland JP, Korde A, Martins AF, Shuhendler AJ, et al. 2024. Combining nuclear medicine with other modalities: future prospect for multimodality imaging. Molecular Imaging 23:15353508241245265

doi: 10.1177/15353508241245265

[92]

Poonam NS, Alam MS, Oberoi P, Mukherjee B. 2022. Dysthyroid optic neuropathy: demographics, risk factors, investigations, and management outcomes. Indian Journal of Ophthalmology 70:4419−4426

doi: 10.4103/ijo.IJO_719_22

[93]

Reuss S. 2023. Dysthyroid optic neuropathy: short- and long-term effects on brain circuitry. Journal of Integrative Neuroscience 22:95

doi: 10.31083/j.jin2204095